Rituxan (rituximab) - Roche
Choroidal Involvement in Nodal Marginal Zone Lymphoma Presenting as Serous Retinal Detachment. (PubMed, Ocul Immunol Inflamm) - Sep 26, 2026 - "The patient was treated with rituximab-based systemic chemotherapy with intrathecal chemotherapy, achieving partial systemic response and complete ocular remission...Systemic evaluation with biopsy of accessible extraocular sites, in conjunction with compatible ocular findings, can establish the diagnosis while avoiding high-risk choroidal biopsy. Early recognition and multidisciplinary collaboration are essential to enable timely diagnosis and systemic treatment." 
Journal • Achromatopsia • CNS Lymphoma • Eye Cancer • Hematological Disorders • Hematological Malignancies • Lymphoma • Marginal Zone Lymphoma • Nodal Marginal Zone Lymphoma • Ocular Inflammation • Oncology • Ophthalmology • Retinal Disorders • Uveitis
http://www.ncbi.nlm.nih.gov/pubmed/42789279
 
Chinadol Wanitpongpun; Kanpirom Tangpontirak; Natthaphop Peenatakapho; Wipada Laovirojjanakul
 
Sep 26, 2026
 
Prev Next